Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

November 23, 2020 14:28 ET | Source: PRA Health Sciences, Inc.

PRA Health Sciences nombra alto funcionario de la FDA para liderar el nuevo Centro Global de Excelencia para la Estrategia de Ensayos Clínicos Descentralizados

RALEIGH, CAROLINA DEL NORTE, Nov. 23, 2020 (GLOBE NEWSWIRE) -- PRA Health Sciences, Inc. (NASDAQ: PRAH) anunció hoy el nombramiento del Dr. Isaac Rodríguez-Chávez, PhD, MHS, MS, como vicepresidente...
November 23, 2020 14:28 ET | Source: PRA Health Sciences, Inc.

PRA 헬스사이언스, 새롭게 건립하는 Global Center of Excellence for Decentralized Clinical Trial Strategy 총괄할 FDA 고위 인사 영입

미국 노스캐롤라이나주 롤리, Nov. 24, 2020 (GLOBE NEWSWIRE) -- PRA 헬스사이언스(PRA Health Sciences, Inc. (NASDAQ: PRAH))는 아이잭 로드리게스-차베스(Isaac Rodriguez-Chavez) 박사(공중보건학 석사, 이학 석사)를 과학, 임상 담당 부사장으로 선임한다고 발표했다....
November 23, 2020 14:28 ET | Source: PRA Health Sciences, Inc.

PRA Health Sciences ernennt hochrangigen FDA-Beamten zum Leiter des neuen Global Center of Excellence for Decentralized Clinical Trial Strategy

RALEIGH, N.C., Nov. 23, 2020 (GLOBE NEWSWIRE) -- PRA Health Sciences, Inc. (NASDAQ: PRAH) gab heute die Ernennung von Isaac Rodriguez-Chavez, PhD, MHS, MS, zum Senior Vice President, Scientific and...
November 19, 2020 16:02 ET | Source: PRA Health Sciences, Inc.

PRA Health Sciences appoints senior FDA official to lead new Global Center of Excellence for Decentralized Clinical Trial Strategy

RALEIGH, N.C. , Nov. 19, 2020 (GLOBE NEWSWIRE) -- PRA Health Sciences, Inc. (NASDAQ: PRAH) announced today the appointment of Isaac Rodriguez-Chavez, PhD, MHS, MS, as Senior Vice President,...
November 04, 2020 16:01 ET | Source: PRA Health Sciences, Inc.

PRA Health Sciences, Inc. Reports Third Quarter 2020 Results and Updates Full Year 2020 Guidance

Net new business of $737.9 million; representing growth of 10.2%; Net book-to-bill of 1.28 excluding reimbursement revenueNet new business of $986.0 million; Net book-to-bill of 1.35 including...
October 07, 2020 17:09 ET | Source: PRA Health Sciences, Inc.

PRA Health Sciences to Report Third Quarter 2020 Earnings

RALEIGH, N.C., Oct. 07, 2020 (GLOBE NEWSWIRE) -- PRA Health Sciences, Inc. (NASDAQ: PRAH) will release its third quarter 2020 results after the market closes on Wednesday, November 4, 2020. The...
October 07, 2020 11:10 ET | Source: PRA Health Sciences, Inc.

PRA Health Sciences seleccionada por BARDA para formar parte de su Red de Estudios Clínicos exclusiva

RALEIGH, Carolina del Norte, Oct. 07, 2020 (GLOBE NEWSWIRE) -- PRA Health Sciences, Inc. (NASDAQ: PRAH) anunció hoy que fue seleccionada por la Autoridad de Investigación y Desarrollo Avanzado...
October 07, 2020 11:10 ET | Source: PRA Health Sciences, Inc.

PRA Health Sciences selecionada pela BARDA como membro da sua exclusiva Rede de Estudos Clínicos

RALEIGH, N.C., Oct. 07, 2020 (GLOBE NEWSWIRE) -- A PRA Health Sciences , Inc.(NASDAQ: PRAH) anunciou hoje que foi selecionada pela Biomedical Advanced Research and Development Authority (BARDA) como...
October 07, 2020 11:10 ET | Source: PRA Health Sciences, Inc.

PRAヘルスサイエンス、BARDAにより専門臨床研究ネットワークのメンバーに選出

PRAは新たな契約の下、公衆衛生の医学的対策開発で生物医学先端研究開発局 (BARDA) を支援ノースカロライナ州ローリー, Oct. 08, 2020 (GLOBE NEWSWIRE) -- PRAヘルスサイエンス (PRA Health Sciences, Inc.、NASDAQ: PRAH) は本日、生物医学先端研究開発局 (Biomedical Advanced Research...
October 07, 2020 11:10 ET | Source: PRA Health Sciences, Inc.

PRA Health Sciences被BARDA选为其独家临床研究网络的成员

北卡罗来纳州罗利市, Oct. 07, 2020 (GLOBE NEWSWIRE) -- Health Sciences, Inc.（NASDAQ：PRAH）今天宣布已被生物医学高级研究与发展管理局（BARDA）选为最新临床研究网络（CSN）的成员。按照临床试验规划和实施（CTPE）合同的规定，...